PMC:7102556 / 19187-19317
Annnotations
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
355 | 43-51 | Species | denotes | patients | Tax:9606 |
356 | 57-61 | Species | denotes | CoVs | Tax:11118 |
368 | 66-75 | Chemical | denotes | ribavirin | MESH:D012254 |
369 | 77-96 | Chemical | denotes | lopinavir/ritonavir | MESH:C558899 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T127 | 66-75 | Chemical | denotes | ribavirin | http://purl.obolibrary.org/obo/CHEBI_63580 |
T128 | 77-96 | Chemical | denotes | lopinavir/ritonavir | http://purl.obolibrary.org/obo/CHEBI_145924 |
T129 | 77-86 | Chemical | denotes | lopinavir | http://purl.obolibrary.org/obo/CHEBI_31781 |
T130 | 87-96 | Chemical | denotes | ritonavir | http://purl.obolibrary.org/obo/CHEBI_45409 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T122 | 0-130 | Sentence | denotes | So far, the most common therapies tried in patients with CoVs are ribavirin, lopinavir/ritonavir, IFN, or their combinations [74]. |
2_test
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
32017984-25278221-69697784 | 126-128 | 25278221 | denotes | 74 |